Skip to main content

Publication, Part of

National Diabetes Audit 2021-22, Young People with Type 2 Diabetes - Overview

Current Chapter

Additional information


Young Type 2 Dashboard is now available

The NDA Young People with Type 2 Dashboard is now available. The latest data is available here:  National Diabetes Audit dashboards.

11 October 2024 09:00 AM

Changes to NDA reporting

NHS England are currently reviewing the routine production of NDA State of the Nation reports. Please note that data will still be released via dashboards and standalone data files whilst this review is being conducted.

To help inform this review we would be grateful if users can provide feedback on their use of the State of the Nation reports using the feedback survey available in the ‘Related links' section of this page.

3 June 2014 00:00 AM

Additional information

Definitions

Antihypertensive treatment

Antihypertensive treatment is medication used to help treat high blood pressure.

Care processes (National Institute for Health and Care Excellence - NICE - recommends all of these at least once a year)

Blood pressure is a measurement of the force driving the blood through the arteries. Blood pressure readings contain 2 figures, e.g.130/80. The first is known as the systolic pressure which is produced when the heart contracts. The second is the diastolic pressure which is when the heart relaxes to refill with blood.

BMI measurement – Body mass index (BMI) is calculated from weight and height. Methods differ between children (up to 18 years old) and adults. In adults, categories are assigned based on BMI ranges and ethnicity group. For children, their BMI is compared to reference values for children of the same sex and similar age that took part in national surveys. Assignments for both groups are:

BMI category Children (centile) Adults – (BMI value)
White
Adults – (BMI value) 
Black, Asian and ethnic minority groups
Underweight Below the 2nd centile <18.5 <18.5
Healthy weight 2nd to 85th centile 18.5 to 24.9  18.5 to 22.9
Overweight 85th to 95th centile  25.0  to 29.9 23.0  to  27.4
Obese Above the 95th centile ≥30.0 ≥27.5

See Methodology of the detailed report for further information.

Serum creatinine – this is a blood test used to measure kidney function.

Urinary albumin – this urine test detects the earliest stages of kidney disease.

Cholesterol  this blood test measures a type of fat that can damage blood vessels.

Foot check – this examination checks the blood supply and sensation (feeling) in the feet. Loss of either is a risk for foot disease.

Smoking status – this records whether the person is a smoker. Smoking increases the risk of heart attacks and stroke for people with diabetes.

HbA1c – this is a blood test for average blood glucose levels during the previous 2 to 3 months.

Diabetes

Diabetes is a condition where the amount of glucose in the blood is too high because the pancreas doesn’t produce enough insulin.  Insulin is a hormone produced by the pancreas that allows glucose to be used as a body fuel and other nutrients to be used as building blocks. There are 2 main types of diabetes: type 1 diabetes (no insulin); type 2 diabetes (insufficient insulin).

Eye exam/retinopathy

Diabetic retinopathy is a microvascular disease specific to the people with diabetes. Everyone with diabetes from the age of 12 is eligible for diabetic eye screening to detect the development of diabetic retinopathy. NICE recommends diabetic eye screening once every 2 years.

Specialist service

This is a service (often hospital based but sometimes delivered in a community setting) which includes diabetes specialists working in multidisciplinary teams. These teams usually comprise physicians (diabetologists), diabetes specialist nurses and dieticians; it may also include clinical psychologists.

Statins

Statins are a group of medicines that can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood. LDL cholesterol is often referred to as "bad cholesterol", and statins reduce the production of it inside the liver.

Treatment Targets (NICE defines target levels to reduce risks of complications for people with diabetes)

HbA1c – the closer this is to normal (less than 42 mmol/mol) the lower is the risk of all long term complications of diabetes.

Blood pressure – high levels are a risk for heart attacks and strokes; they also drive progression of eye and kidney disease.

Statins

  • Primary prevention of cardiovascular disease (CVD) – the prescription of statins for people with diabetes aged 40 to 80 years with no history of CVD to reduce the risk of CVD.
  • Secondary prevention of CVD – the prescription of statins for people with diabetes (any age) with a history of CVD to reduce the risk of CVD.
  • Combined prevention of CVD – the prescription of statins for people with diabetes that fall into either of the primary or secondary prevention groups.

Meeting all 3 treatment targets – having HbA1c ≤ 58mmol/mol, blood pressure ≤140/80 and for people falling in the combined prevention CVD group: receiving statins.


Statistical terms

Where a result is flagged as significant at 0.05 level, there is up to a 5% probability of the observed result being due to chance.

Logistic regression is used to examine the relationship between an outcome (e.g. achieving an HbA1c ≤ 58 mmol/mol) and related variables (e.g. diabetes duration). 

For this report, each variable is split into groups (e.g. ethnicity is split into white, Asian, black, mixed, other and not stated). One of these groups is chosen to be the reference group which all other groups within the variable are compared to. The reference groups used in the models in this report are:

Variable Reference group
Sex Male
Deprivation Least deprived
Ethnicity White
Diabetes duration Less than 2 years
BMI Healthy weight

2 outputs are particularly useful when interpreting the results of a logistic regression model:

  • The c statistic can be used to assess the goodness of fit, with values ranging from 0.5 to 1.0. A value of 0.5 indicates that the model is no better than chance at making a prediction of membership in a group and a value of 1.0 indicates that the model perfectly identifies those within a group and those not. Models are typically considered reasonable when the c statistic is higher than 0.7 and strong when the c statistic exceeds 0.8 (Hosmer and Lemeshow, 2000 (1)).
  • Odds ratios (OR) illustrate how strongly a particular value of a variable is associated with the outcome. The further from 1 the ratio is (either above or below), the stronger the association between it and the outcome. For example, an odds ratio of 0.764 would suggest a stronger association than an odds ratio of 0.830. An odds ratio of 1 would show that the variable value has no bearing on how likely the outcome is. 

The degree of uncertainty inherent in the odds ratio is described by the confidence interval. The wider the confidence interval, the less certainty there is in the odds ratio. If the confidence intervals are either side of 1 (the line of no effect) this indicates that the value taken by the variable (e.g. unknown diabetes duration) has no bearing on how likely the outcome is (e.g. achieving an HbA1c ≤ 58 mmol/mol). Where the confidence interval approaches 1 this indicates that the association with the outcome may be weak. Odds ratios can be displayed on a forest plot (see example forest plot in Figure 7 below).

Figure 6: Forest plot showing odds ratios indicating how strongly variables are associated with the outcome:

Forest plot showing odds ratios indicating how strongly variables are associated with the outcome

Notes:

1. Hosmer DW, Lemeshow S (2000) Applied Logistic Regression (2nd Edition) New York, NY: John Wiley & Sons.


Notes and additional information

Disclosure control
  • Disclosure control has been applied to mitigate the risk of patient identification.
  • Zeros are reported, and all numbers are rounded to the nearest 5, unless the number is 1 to 7, in which case it is rounded to 5. This allows for more granular data to be made available.
  • Rounded numbers are used to calculate percentages therefore numbers may not sum as expected.
  • Percentages are not calculated where the rounded denominator is 20 or less (small denominators), and where numbers are small percentages are volatile and should be treated with caution.
Time period covered
  • For the majority of the analysis, the analysis covers the 2021-22 audit year. For the trend analysis, the analysis covers 5 years of analysis, 2017-18 to 2021-22.
  • The National Diabetes Audit (NDA) years covered are 2017-18 to 2021-22 which covers the period 01 January 2017 to 31 March 2022.
  • The National Paediatric Diabetes Audit (NPDA) years covered are 2017-18 to 2021-22 which covers the period 01 April 2017 to 31 March 2022.
Quality Improvement Collaboratives
  • NDA data is available for all work streams (1). Improvement methodologies have been advocated since 2016/17 (2,3). Presently the NDA is supporting application of these principles via Quality Improvement Collaboratives (4). We recommend that ICBs advocate and support use of these approaches to improving overall achievements and reducing variation.

Prepared in collaboration with:

National Diabetes Audit, 2021-22 Young People with Type 2 Diabetes

Published by NHS England

Part of the Government Statistical Service

 

For further information

https://digital.nhs.uk

0300 303 5678

[email protected]

 

© 2023 NHS England. All rights reserved.

This work may be re-used by NHS and government organisations without permission.



Last edited: 11 October 2024 9:04 am


Pages in this publication